300244.SZ Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:04):

Stats
Šios dienos apimtis	21.97M
Vidutinė apimtis	13.14M
Rinkos kapitalizacija	8.85B
EPS	CNY0.120 ( 2023-10-27 )
Kita pelno data	( CNY0.370 ) 2024-05-20
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	52.22
ATR14	CNY0.0140 (0.10%)

Tūris Koreliacija

Ilgas: -0.08 (neutral)

Trumpas: -0.16 (neutral)

Signal:(31.331) Neutral

Dian Diagnostics Group Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Dian Diagnostics Group Koreliacija - Valiuta/Žaliavos

0.41
( neutral )

0.20
( neutral )

0.00
( neutral )

-0.35
( neutral )

0.64
( weak )

-0.05
( neutral )

Dian Diagnostics Group Finansinės ataskaitos

Annual	2023
Pajamos:	CNY13.36B
Bruto pelnas:	CNY4.06B (30.36 %)
EPS:	CNY0.500

FY	2023
Pajamos:	CNY13.36B
Bruto pelnas:	CNY4.06B (30.36 %)
EPS:	CNY0.500

FY	2022
Pajamos:	CNY20.28B
Bruto pelnas:	CNY7.54B (37.16 %)
EPS:	CNY2.30

FY	2021
Pajamos:	CNY13.08B
Bruto pelnas:	CNY5.01B (38.26 %)
EPS:	CNY1.874

Financial Reports:

No articles found.

Dian Diagnostics Group

Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. The company operates 40 chain laboratories worldwide. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment and consumables; provision of medical equipment, drugs, clinical samples, biological products, virus and microorganisms, finished blood, live animals, compounds, and diagnostic reagents, as well as other cold chain transportation, warehousing services, cold chain product sales, and technical services. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.